Alerts will be sent to your verified email
Verify Email
CBPL
|
Chandra Bhagat Pharm
|
ANG Lifesciences
|
Medistep Healthcare
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
3.03 % | 3.78 % | 24.77 % |
|
5yr average Equity Multiplier
|
2.92 | 3.3 | 1.32 |
|
5yr Average Asset Turnover Ratio
|
1.46 | 0.77 | 2.13 |
|
5yr Avg Net Profit Margin
|
0.71 % | -2.26 % | 8.79 % |
|
Price to Book
|
1.07 | 0.56 | 1.9 |
|
P/E
|
37.03 | 0.0 | 7.8 |
|
5yr Avg Cash Conversion Cycle
|
123.14 Days | 70.26 Days | 115.71 Days |
|
Inventory Days
|
97.15 Days | 107.37 Days | 9.08 Days |
|
Days Receivable
|
158.67 Days | 274.82 Days | 124.47 Days |
|
Days Payable
|
38.34 Days | 235.98 Days | 17.5 Days |
|
5yr Average Interest Coverage Ratio
|
1.63 | 1.81 | 96.98 |
|
5yr Avg ROCE
|
10.9 % | 15.08 % | 33.38 % |
|
5yr Avg Operating Profit Margin
|
1.16 % | 7.68 % | 11.92 % |
|
5 yr average Debt to Equity
|
0.76 | 0.97 | 0.04 |
|
5yr CAGR Net Profit
|
35.25 % | n/a | 35.1 % |
|
5yr Average Return on Assets
|
1.04 % | 1.04 % | 18.77 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
72.19 % | 70.6 % | 68.96 % |
|
Share Pledged by Promoters
|
0.0 | 44.88 % | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
1.77 % | -0.55 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandra Bhagat Pharm
|
ANG Lifesciences
|
Medistep Healthcare
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
Location Wise Break-Up
|